Why the study?
Are low molecular weight heparins safer than unfractionated heparin in the treatment of venous thromboembolism?
Population
Patients with venous thromboembolism
Comparison
Low molecular weight heparins (LMWHs) vs Unfractionated heparin (UFH)
Design
Review
Authors
Loading...
LMWHs may be favored for outpatient VTE treatment due to practical and specific safety benefits; leaves open overall superiority versus UFH.
Are low molecular weight heparins safer than unfractionated heparin in the treatment of venous thromboembolism?
LMWHs provide practical and specific safety advantages over UFH for VTE treatment, including outpatient use and reduced risks of HIT and osteoporosis.
Bernardi et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: